NAHDI - Disclosures
Nahdi board approves 25% dividend for H1 2024
Argaam 31/07/2024
Nahdi's board nods to 30% dividend payout for H2 2023
Argaam 17/03/2024
Nahdi board declares 25% cash dividend for H1 2023
Argaam 02/08/2023
Nahdi board approves 30% cash dividend for H2 2022
Argaam 20/03/2023
Nahdi shut 75 pharmacies, opened 18 larger in 2022 to provide primary healthcare services: CEO
Argaam Special 15/02/2023
Nahdi sets up new company owned by subsidiaries in Egypt
Argaam 29/09/2022
Nahdi inaugurates third clinic in Jeddah
Argaam 05/09/2022
Nahdi board declares 23% cash dividend for H1 2022
Argaam 09/08/2022
Nahdi shareholders authorize board to pay interim dividends for 2022
Argaam 25/05/2022
Nahdi Medical debuts on Tadawul today; fifth listing of 2022
Argaam Special 22/03/2022
Nahdi Medical’s retail offering 13x covered, 3 shares minimum allocation
Argaam 20/03/2022
Retail subscription for Nahdi Medical IPO kicks off today
Argaam Special 13/03/2022
Nahdi sets final IPO price at SAR 131, order book 59x covered
Argaam 10/03/2022
Nahdi Medical issues prospectus to float 39 mln shares on Tadawul
Argaam 21/02/2022